ASTRO Selects the Data for Center Stage at Largest Annual Meeting of Radiation Oncologists SUNNYVALE, Calif. , Sept. 27, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, 21 center study showed 97 percent of low- and intermediate-risk prostate
Erectile Function Preserved in More Than 80 Percent of Patients SUNNYVALE, Calif., Oct 01, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today publication of results from a study of early stage prostate cancer
New System Will Play a Key Role in Delivering Radiation Treatments in One of the Largest Cancer Facilities in Washington State MADISON, Wis. , Jan. 25, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Providence Swedish Radiosurgery Center in Seattle, Washington is
Montérégie Integrated Cancer Center , part of Charles-LeMoyne Hospital , is a center of excellence and recognized leader in the treatment of cancer in the province of Quebec The Radixact System is equipped with ClearRT™ and Synchrony ® , advanced technologies designed to improve treatment outcomes
SUNNYVALE, Calif. , Feb. 1, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Robert C. Kill to the company's Board of Directors, effective as of January 30, 2023 . Mr. Kill is a skilled healthcare executive with more than 30 years' experience transforming
Attendance Doubles with More Than 175 Health Professionals From 13 Countries Participating SUNNYVALE, Calif., May 5 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the Robotic Radiosurgery Course held on April 11 and
SUNNYVALE, Calif., May 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Securities and Exchange Commission has declared effective the company's Form S-4 Registration Statement relating to the
--Attendance Doubles with More Than 200 Health Professionals From 28 Countries Participating SUNNYVALE, Calif., April 10, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the second European
Advanced, 10-Day Radiation Treatment Regimen Enables Patients to Get Back to Their Life, Faster SUNNYVALE, Calif. , Jan. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, phase II trial of 338 women with low-risk breast cancer showed 98.8
CyberKnife for Installation at Gyeongsang National University Hospital Will Expand Patient Access SUNNYVALE, Calif ., Aug. 12 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the Gyeongsang National University Hospital
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
